Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2778)	3/7/2011 4:29:32 PM
From: DewDiligence_on_SI	of 3027

As long as the probability of a preliminary injunction is something greater than zero (which is assuredly is), Teva ought to want a speedy end to the Lovenox patent litigation in order to accelerate the time when a PI could be lifted and Teva could be begin to sell product. However, the above logic would pertain only if Teva thought it had a realistic chance of getting FDA approval in the next two years, and I would be willing to bet* that Teva does not think it has that. Hence, under the actual circumstances, Teva might as well let the litigation proceed slowly. I’m wondering how long it will take until you move off your position that Teva has been telling the truth about its Lovenox program to the investment community and that the probability of FDA approval is “95%.” Regards, Dew Actually, you and I already have* such a bet :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next